Clinical Trial: TOS-358-001

Trial Status: Open
Disease Type: Solid Tumors All
Trial ID TOS-358-001
Sponsor ID Totus

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors


Fairfax Office

Learn More About This Trial
Other Relevant Trials
Trial ID NP-G2-044-P2-01
Sponsor ID Novita

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

Trial ID KB-0742-1001
Sponsor ID Kronos Bio

“Phase 1, first-in-human, open-label dose escalation and cohort expansion study of KB-0742 in patients with relapsed or refractory solid tumors or non-Hodgkin lymphoma”